|
ABOS
|
Acumen Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
ACIU
|
AC Immune SA
|
US
|
NASDAQ
|
|
AGEN
|
Agenus Inc.
|
US
|
NASDAQ
|
|
ALZN
|
Alzamend Neuro, Inc.
|
US
|
NASDAQ
|
|
AMED
|
Amedisys Inc
|
US
|
NASDAQ
|
|
AMLX
|
Amylyx Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ANVS
|
Annovis Bio, Inc.
|
US
|
NYSE
|
|
ATHE
|
Alterity Therapeutics Limited
|
US
|
NASDAQ
|
|
AVXL
|
Anavex Life Sciences Corp.
|
US
|
NASDAQ
|
|
AXSM
|
Axsome Therapeutics, Inc.
|
US
|
NASDAQ
|
|
BIIB
|
Biogen Idec Inc.
|
US
|
NASDAQ
|
|
BLU
|
BELLUS Health Inc.
|
US
|
NASDAQ
|
|
BNOX
|
Bionomics Limited
|
US
|
NASDAQ
|
|
CGTX
|
Cognition Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CYTH
|
Cyclo Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DNLI
|
Denali Therapeutics Inc.
|
US
|
NASDAQ
|
|
EHAB
|
Enhabit, Inc.
|
US
|
NYSE
|
|
GLMD
|
Galmed Pharmaceuticals Ltd.
|
US
|
NASDAQ
|
|
IDRA
|
Idera Pharmaceuticals, Inc.
|
US
|
NASDAQ
|